Primary Site >> Colorectal Cancer
Gene >> CDK5
| 1. | |||||||||||
| Journal: | Cancer Biol Ther. 2005 Nov;4(11):1211-5. Epub 2005 Nov 8. | ||||||||||
| Title: | Aberrant splicing of cables gene, a CDK regulator, in human cancers. | ||||||||||
| Author: | Zhang, Hui|Duan, Hai Ou|Kirley, Sandra D|Zukerberg, Lawrence R|Wu, Chin-Lee | ||||||||||
| PMID: | 16177568 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Oncol. 2006 Jan;28(1):191-4. | ||||||||||
| Title: | CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation. | ||||||||||
| Author: | Kim, Eugene|Chen, Fei|Wang, Chia-Chi|Harrison, Lawrence E | ||||||||||
| PMID: | 16327995 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Cancer Ther. 2009 Jan;8(1):194-202. | ||||||||||
| Title: | Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer. | ||||||||||
| Author: | Martinez-Cardus, Anna|Martinez-Balibrea, Eva|Bandres, Eva|Malumbres, Raquel|Gines, Alba|Manzano, Jose Luis|Taron, Miquel|Garcia-Foncillas, Jesus|Abad, Albert | ||||||||||
| PMID: | 19139129 | ||||||||||
| 4. | |||||||||||
| Journal: | Bioorg Med Chem Lett. 2012 Nov 15;22(22):6947-51. | ||||||||||
| Title: | Design, synthesis and anticancer activity of 1-acyl-3-amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives. | ||||||||||
| Author: | Bai, Xiao-Guang|Yu, Dong-Ke|Wang, Ju-Xian|Zhang, Hao|He, Hong-Wei|Shao, Rong-Guang|Li, Xue-Mei|Wang, Yu-Cheng | ||||||||||
| PMID: | 23036956 | ||||||||||
| 5. | |||||||||||
| Journal: | Chem Biol Drug Des. 2015 Dec;86(6):1528-40. | ||||||||||
| Title: | Characterization of a Pyrazolo[4,3-d]pyrimidine Inhibitor of Cyclin-Dependent Kinases 2 and 5 and Aurora A With Pro-Apoptotic and Anti-Angiogenic Activity In Vitro. | ||||||||||
| Author: | Reznickova, Eva|Weitensteiner, Sabine|Havlicek, Libor|Jorda, Radek|Gucky, Tomas|Berka, Karel|Bazgier, Vaclav|Zahler, Stefan|Krystof, Vladimir|Strnad, Miroslav | ||||||||||
| PMID: | 26198005 | ||||||||||
| 6. | |||||||||||
| Journal: | Cell Death Dis. 2016 Oct 13;7(10):e2415. | ||||||||||
| Title: | CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis. | ||||||||||
| Author: | Zhuang, Kangmin|Zhang, Juchang|Xiong, Man|Wang, Xianfei|Luo, Xiaobei|Han, Lu|Meng, Yan|Zhang, Yali|Liao, Wenting|Liu, Side | ||||||||||
| PMID: | 27735944 | ||||||||||
| 7. | |||||||||||
| Journal: | Bioorg Med Chem Lett. 2017 Sep 15;27(18):4399-4404. | ||||||||||
| Title: | Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors. | ||||||||||
| Author: | Park, Sun Jun|Kim, Eunjin|Yoo, Miyoun|Lee, Joo-Youn|Park, Chi Hoon|Hwang, Jong Yeon|Ha, Jae Du | ||||||||||
| PMID: | 28827110 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncotarget. 2017 Dec 28;9(4):5216-5232. | ||||||||||
| Title: | Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. | ||||||||||
| Author: | Robb, Caroline M|Kour, Smit|Contreras, Jacob I|Agarwal, Ekta|Barger, Carter J|Rana, Sandeep|Sonawane, Yogesh|Neilsen, Beth K|Taylor, Margaret|Kizhake, Smitha|Thakare, Rhishikesh N|Chowdhury, Sanjib|Wang, Jing|Black, Jennifer D|Hollingsworth, Michael A|Bra | ||||||||||
| PMID: | 29435174 | ||||||||||
| 9. | |||||||||||
| Journal: | Mol Cancer Ther. 2018 Jun;17(6):1156-1166. | ||||||||||
| Title: | ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. | ||||||||||
| Author: | Patel, Hetal|Periyasamy, Manikandan|Sava, Georgina P|Bondke, Alexander|Slafer, Brian W|Kroll, Sebastian H B|Barbazanges, Marion|Starkey, Richard|Ottaviani, Silvia|Harrod, Alison|Aboagye, Eric O|Buluwela, Laki|Fuchter, Matthew J|Barrett, Anthony G M|Coombe | ||||||||||
| PMID: | 29545334 | ||||||||||